Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Chandrasekaran R, Mac Aogáin M, Chalmers JD, Elborn SJ, Chotirmall SH.

BMC Pulm Med. 2018 May 22;18(1):83. doi: 10.1186/s12890-018-0638-0. Review.

2.

Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury.

Proudfoot A, Bayliffe A, O'Kane CM, Wright T, Serone A, Bareille PJ, Brown V, Hamid UI, Chen Y, Wilson R, Cordy J, Morley P, de Wildt R, Elborn S, Hind M, Chilvers ER, Griffiths M, Summers C, McAuley DF.

Thorax. 2018 Aug;73(8):723-730. doi: 10.1136/thoraxjnl-2017-210305. Epub 2018 Jan 29.

3.

European Respiratory Society guidelines for the management of adult bronchiectasis.

Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, De Soyza A, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD.

Eur Respir J. 2017 Sep 9;50(3). pii: 1700629. doi: 10.1183/13993003.00629-2017. Print 2017 Sep.

PMID:
28889110
4.

Chronic lung disease in common variable immune deficiency (CVID): A pathophysiological role for microbial and non-B cell immune factors.

Mooney D, Edgar D, Einarsson G, Downey D, Elborn S, Tunney M.

Crit Rev Microbiol. 2017 Aug;43(4):508-519. doi: 10.1080/1040841X.2016.1268568. Epub 2017 Jan 10. Review.

PMID:
28068853
5.

Interventions for enhancing adherence to treatment in adults with bronchiectasis.

McCullough A, Thomas ET, Ryan C, Bradley JM, O'Neill B, Elborn S, Hughes C.

Cochrane Database Syst Rev. 2015 Nov 18;(11):CD011023. doi: 10.1002/14651858.CD011023.pub2. Review.

PMID:
26576499
6.

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety.

Quittner AL, Abbott J, Georgiopoulos AM, Goldbeck L, Smith B, Hempstead SE, Marshall B, Sabadosa KA, Elborn S; International Committee on Mental Health; EPOS Trial Study Group.

Thorax. 2016 Jan;71(1):26-34. doi: 10.1136/thoraxjnl-2015-207488. Epub 2015 Oct 9.

7.

A new Clinical Trials Directive to boost academic trials?

De Boeck K, Tiddens H, Elborn S, Fajac I; European Cystic Fibrosis Society (ECFS) and the ECFS Clinical Trial Network.

Lancet Respir Med. 2013 Apr;1(2):99-101. doi: 10.1016/S2213-2600(13)70041-9. Epub 2013 Mar 21. No abstract available.

PMID:
24429080
8.

An official American Thoracic Society research statement: comparative effectiveness research in pulmonary, critical care, and sleep medicine.

Carson SS, Goss CH, Patel SR, Anzueto A, Au DH, Elborn S, Gerald JK, Gerald LB, Kahn JM, Malhotra A, Mularski RA, Riekert KA, Rubenfeld GD, Weaver TE, Krishnan JA; American Thoracic Society Comparative Effectiveness Research Working Group.

Am J Respir Crit Care Med. 2013 Nov 15;188(10):1253-61. doi: 10.1164/rccm.201310-1790ST.

9.

Effect of simvastatin on physiological and biological outcomes in patients undergoing esophagectomy: a randomized placebo-controlled trial.

Shyamsundar M, McAuley DF, Shields MO, MacSweeney R, Duffy MJ, Johnston JR, McGuigan J, Backman JT, Calfee CS, Matthay MM, Griffiths MJ, McDowell C, Elborn SJ, OʼKane CM.

Ann Surg. 2014 Jan;259(1):26-31. doi: 10.1097/SLA.0b013e31829d686b.

PMID:
23817506
10.

Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN).

De Boeck K, Bulteel V, Tiddens H, Wagner T, Fajac I, Conway S, Dufour F, Smyth AR, Lee T, Sermet I, Kassai B, Elborn S; ECFS-CTN network partners.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S67-74. doi: 10.1016/S1569-1993(11)60010-6.

11.

Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population.

Parkins MD, Parkins VM, Rendall JC, Elborn S.

Ther Adv Respir Dis. 2011 Apr;5(2):105-19. doi: 10.1177/1753465810386051. Epub 2010 Nov 15. Review.

PMID:
21078692
12.

Identification of airborne bacterial and fungal species in the clinical microbiology laboratory of a university teaching hospital employing ribosomal DNA (rDNA) PCR and gene sequencing techniques.

Nagano Y, Walker J, Loughrey A, Millar C, Goldsmith C, Rooney P, Elborn S, Moore J.

Int J Environ Health Res. 2009 Jun;19(3):187-99. doi: 10.1080/09603120802474229.

PMID:
20183192
13.

Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro.

Deligianni E, Pattison S, Berrar D, Ternan NG, Haylock RW, Moore JE, Elborn SJ, Dooley JS.

BMC Microbiol. 2010 Feb 8;10:38. doi: 10.1186/1471-2180-10-38.

14.

European best practice guidelines for cystic fibrosis neonatal screening.

Castellani C, Southern KW, Brownlee K, Dankert Roelse J, Duff A, Farrell M, Mehta A, Munck A, Pollitt R, Sermet-Gaudelus I, Wilcken B, Ballmann M, Corbetta C, de Monestrol I, Farrell P, Feilcke M, Férec C, Gartner S, Gaskin K, Hammermann J, Kashirskaya N, Loeber G, Macek M Jr, Mehta G, Reiman A, Rizzotti P, Sammon A, Sands D, Smyth A, Sommerburg O, Torresani T, Travert G, Vernooij A, Elborn S.

J Cyst Fibros. 2009 May;8(3):153-73. doi: 10.1016/j.jcf.2009.01.004. Epub 2009 Feb 26.

15.

Bronchial associated lymphoid tissue (BALT) lymphoma presenting as chronic lung sepsis.

Hoeritzauer AI, Venkatraman L, Manus KM, Kettle P, Sah S, Elborn S.

BMJ Case Rep. 2009;2009. pii: bcr03.2009.1716. doi: 10.1136/bcr.03.2009.1716. Epub 2009 Sep 7.

16.

Highlights of a workshop to discuss targeting inflammation in cystic fibrosis.

Banner KH, De Jonge H, Elborn S, Growcott E, Gulbins E, Konstan M, Moss R, Poll C, Randell SH, Rossi AG, Thomas L, Waltz D.

J Cyst Fibros. 2009 Jan;8(1):1-8. doi: 10.1016/j.jcf.2008.10.002. Epub 2008 Nov 20. Review.

17.

A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD.

Bradley JM, Lasserson T, Elborn S, Macmahon J, O'neill B.

Chest. 2007 Jan;131(1):278-85. Review.

PMID:
17218587
18.

Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.

Courtney JM, Plant BJ, Morgan K, Rendall J, Gallagher C, Ennis M, Kalsheker N, Elborn S, O'Connor CM.

Pediatr Pulmonol. 2006 Jun;41(6):584-91.

PMID:
16617455
19.

Progress towards gene therapy for cystic fibrosis.

Tate S, Elborn S.

Expert Opin Drug Deliv. 2005 Mar;2(2):269-80. Review.

PMID:
16296753
20.

Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim.

Macartney C, Burke E, Elborn S, Magee N, Noone P, Gleadhill I, Allen D, Kettle P, Drake M.

Leuk Lymphoma. 2005 Oct;46(10):1523-6.

PMID:
16194900
21.

Standards of care for patients with cystic fibrosis: a European consensus.

Kerem E, Conway S, Elborn S, Heijerman H; Consensus Committee.

J Cyst Fibros. 2005 Mar;4(1):7-26. Review. No abstract available.

22.
23.

Organisms isolated from adults with cystic fibrosis.

McManus TE, McDowell A, Moore JE, Elborn SJ.

Ann Clin Microbiol Antimicrob. 2004 Dec 15;3:26.

24.

Energy balance in cystic fibrosis when stable and during a respiratory exacerbation.

Mc Closkey M, Redmond AO, Mc Cabe C, Pyper S, Westerterp KR, Elborn SJ.

Clin Nutr. 2004 Dec;23(6):1405-12.

PMID:
15556263
25.

Foreword.

Elborn S.

J Cyst Fibros. 2003 Jun;2(Suppl 1):1. No abstract available.

26.

Subjective benefit of inhaled therapies in patients with bronchiectasis: a questionnaire study.

O'Neill B, Bradley JM, Macmahon J, Elborn S.

Int J Clin Pract. 2004 May;58(5):441-3.

PMID:
15206498
27.

Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis.

De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, Gould K, Corris PA.

Lancet. 2001 Nov 24;358(9295):1780-1.

PMID:
11734238
28.

Individuals with cystic fibrosis do not display impaired endothelial function or evidence of oxidative damage in endothelial cells exposed to serum.

McGrath LT, McCall D, Hanratty CG, Brennan S, Devine A, McCauley DF, Silke B, Elborn S.

Clin Sci (Lond). 2001 Nov;101(5):507-13.

PMID:
11672456
29.

Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis.

Bradley J, McAlister O, Elborn S.

Eur Respir J. 2001 Apr;17(4):712-5.

30.

Breath isoprene during acute respiratory exacerbation in cystic fibrosis.

McGrath LT, Patrick R, Mallon P, Dowey L, Silke B, Norwood W, Elborn S.

Eur Respir J. 2000 Dec;16(6):1065-9.

31.

Lung transplantation for cystic fibrosis; the effect of B cepacia genomovars on post transplant outcomes.

De Soyza A, Archer L, McDowell A, Moore J, Dark JH, Elborn S, Mahenthiralingam E, Corris PA, Gould K.

J Heart Lung Transplant. 2001 Feb;20(2):158. No abstract available.

PMID:
11250232
32.

Reliability, repeatability, and sensitivity of the modified shuttle test in adult cystic fibrosis.

Bradley J, Howard J, Wallace E, Elborn S.

Chest. 2000 Jun;117(6):1666-71.

PMID:
10858400
33.
34.

Oxidative stress during acute respiratory exacerbations in cystic fibrosis.

McGrath LT, Mallon P, Dowey L, Silke B, McClean E, McDonnell M, Devine A, Copeland S, Elborn S.

Thorax. 1999 Jun;54(6):518-23.

35.

Validity of a modified shuttle test in adult cystic fibrosis.

Bradley J, Howard J, Wallace E, Elborn S.

Thorax. 1999 May;54(5):437-9.

36.

The management of young adults with cystic fibrosis: 'genes, jeans and genies'.

Elborn S.

Disabil Rehabil. 1998 Jun-Jul;20(6-7):217-25. Review.

PMID:
9637930
37.

Fever associated with intravenous antibiotics in adults with cystic fibrosis.

Mallon P, Murphy P, Elborn S.

Lancet. 1997 Dec 6;350(9092):1676-7. No abstract available.

PMID:
9400516
38.

Clinically significant pulmonary barotrauma after inflation of party balloons.

Mumford AD, Ashkan K, Elborn S.

BMJ. 1996 Dec 21-28;313(7072):1619. No abstract available.

39.

Misleading experiments.

Elborn S.

Nurs Stand. 1991 Jul 17;5(43):41-2. doi: 10.7748/ns.5.43.41.s46.

PMID:
27524594
40.

The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis.

Taggart AJ, McDermott B, Delargy M, Elborn S, Forbes J, Roberts SD, Ahnfelt NO.

Scand J Rheumatol Suppl. 1987;64:29-36.

PMID:
2893450

Supplemental Content

Loading ...
Support Center